FDLI
Executive Summary
Former U.S. Pharmacopeia CEO Jerome Halperin will replace John Villforth as president of the Food & Drug Law Institute July 1. Halperin serves as FDLI treasurer and has been a member of the board of directors since 1991. Prior to his tenure at USP from 1990 to 2000, Halperin worked six years as VP-technology for CIBA Consumer Pharmaceuticals. He previously served as FDA Office of Drugs Acting Director
You may also be interested in...
FDLI CEO has device background
Food & Drug Law Institute names former Carl Zeiss CEO James Kelly president and CEO effective Aug. 14. Prior to working at Zeiss, Kelly held various positions with Siemens Medical, including head of human resources. Kelly's device background contrasts with his predecessor Jerome Halperin, who headed U.S. Pharmacopeia prior to joining FDLI nearly five years ago (1"The Pink Sheet" April 2, 2001, p. 36)...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011